Document is current
Any future updates will be listed below
-
Authors
Schwarzová, Barbora https://orcid.org/0000-0001-7663-7647
Stüdemann, Tim https://orcid.org/0000-0003-1987-1589
Sönmez, Muhammed https://orcid.org/0009-0004-6040-3757
Rössinger, Judith https://orcid.org/0000-0002-0801-7283
Pan, Bangfen
Eschenhagen, Thomas https://orcid.org/0000-0003-1750-1170
Stenzig, Justus https://orcid.org/0000-0003-3932-8372
Wiegert, J. Simon https://orcid.org/0000-0003-0893-9349
Christ, Torsten https://orcid.org/0000-0002-8935-5304
Weinberger, Florian https://orcid.org/0000-0002-1961-0517
-
Funding
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 30 May 2023
Revised: 27 September 2023
Accepted: 6 October 2023
First Online: 21 October 2023
Declarations
:
: Reprogramming of the UKEi001-A line was approved by the Ethical Committee of the University Medical Center Hamburg-Eppendorf (Az. PV4798/28.10.2014). The line has been registered at the Human Pluripotent Stem Cell Registry ().
: The authors declare no competing interests.
